In this study, we observed that inclusion of a large portion of ICD region of HER2 antigen that contains several immunogenic epitopes but not the kinase domain in the cellular cancer vaccine improved the antitumor effect of the vaccine without a significant induction of Erk phosphorylation, one of the indicators of oncogenic HER2 signaling. This evidence concerns the gene ERBB2 and cancer.